Delivery Order SPE2DB22D2206-SPE2DB26FDW12
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,528.93 to AmerisourceBergen Drug Corp for 500 tablets of Cetirizine HCL 10 mg, with an ultimate completion date of July 24, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award to supply pharmaceutical products supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Cetirizine HCL 5 mg tablets (100-count packages) with a ceiling value of $7,861.18. This firm fixed price delivery order, with an ultimate completion date of September 17, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract was awarded on a competitive basis with no set-aside designation and will be performed at...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 14, 2025, for Cetirizine HCL 10 mg tablets (100-count) with a ceiling value of $1,088.45. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cetirizine HCL 5 mg tablets (100-count units) on September 10, 2025, with a ceiling value of $4,911.62 and ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,284.65 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100-count packages) on July 14, 2025, with completion targeted for July 15, 2025. This firm fixed-price, competitively awarded delivery order carries no set-aside designation and represents a continuation of the contractor's role as a critical pharmaceutical supplier to federal healthcare systems. The place of performance is listed as...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 10 mg tablets in quantities of 100 units under a firm fixed-price contract. The award, valued at $2,591.90, was competitively awarded without set-aside designation and reflects a completion date of August 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 10 mg tablets (500-count) with a contract ceiling value of $1,396.35. This competitively awarded, firm fixed-price delivery order was executed on April 24, 2025, with an ultimate completion date of April 25, 2025. The contract involves no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $14,394.77 for 500 tablets of Cetirizine HCL 10 mg on September 25, 2025, with completion scheduled for September 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $21,296.45 to AmerisourceBergen Drug Corp for 500 tablets of Cetirizine HCL 10 mg, with a completion date of September 30, 2025. This competitive award, issued on September 29, 2025, involves firm fixed pricing with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,119.60 to AmerisourceBergen Drug Corp for Cetirizine HCL 10 mg tablets in unit dose packaging containing 100 tablets. This is a firm fixed price delivery order with no set-aside designation, competitively awarded and due for completion by July 28, 2025. The order will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDW12Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,078.62 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 5 mg tablets (100 count) with a completion date of November 3, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, continues to serve as a critical vendor for federal medical procurement needs through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. This prime indefinite delivery vehicle enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract is structured to support DLA's broader pharmaceutical procurement strategy, positioning AmerisourceBergen as a key provider within the federal medical supply network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 10/31/25 |